In mice, MLL fusion proteins were able to transform both HSC enriched LSK cells and progenitor cells, and enhanced Evi1 expression by direct promoter binding – remarkably only in LSK-, but not progenitor-, derived AML [17,106,108–111]. This evidence concerns the gene KMT2A and acute myeloid leukemia.